Edgewell Personal Care Company (EPC) Fair Value & Analysis
Consumer Defensive · US · Market cap $1.1B
Analysis
Edgewell Personal Care Company (EPC) currently trades at $26.22, while our model-based Fair Value estimate is $11.58 — implying the stock looks roughly 55.8% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Edgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet Shave, Sun and Skin Care, and Feminine Care. The Wet Shave segment offers razor systems, such as razor handles and refillable blades, and disposable shave products for men and women under the Schick and Wilkinson Sword brands; shave preparation products comprising shaving gels and creams under the Edge, Skintimate, Billie, Shave Guard brands; and private label and disposable razors, shaving systems, and replacement blades. Its Sun and Skin Care segment provides sun care products, including general protection, sport, kids, baby, tanning, and after sun products under the Banana Boat and Hawaiian Tropic brands; antibacterial hand wipes and other related products under the Wet Ones brand; skin care products for men under the Bulldog and Jack Black brands; and beard, hair, and skin care products under the Cremo brand. The Femin…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.